Phase II Trial of Erlotinib, Prior to Surgery or Radiation in Patients With Squamous Cell Cancers (SCC) of the Skin

Name: Phase II Trial of Erlotinib, Prior to Surgery or Radiation in Patients With Squamous Cell Cancers (SCC) of the Skin
Published: 2011
License: Public Domain

M.D. Anderson Cancer Center · 2011

ClinicalTrials.gov · Datasets · License: Public Domain · 2011

Open Source ↗

egfr radiation-therapy skin-cancer

skin cancer, erlotinib, erlotinib hydrochloride, osi-774, tarceva, squamous cell carcinoma of the skin, aggressive cutaneous squamous cell carcinoma, cscc, local surgery, radiation therapy, epidermal growth factor receptor, egfr

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 805785
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.